Skip to main content
MarketsSingle-sourceLow
2.0

NewAmsterdam Pharma Co N.V. reports executive or director departure

NewAmsterdam Pharma filed an 8-K disclosing a change in leadership or board composition under Item 5.02. The filing confirms a departure or appointment, though specific names and roles remain to be detailed in the full document.

SEC EDGAR 8-K Filings2 days agoNL, USCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

Entities

countrycountry
Source

Related signals

8 found